Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Apr 29, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has named Ora Hirsch Pescovitz to serve on its board of directors. Pescovitz, who will replace W. Ann Reynolds, is executive VP for medical affairs and Health Systems CEO at the University of Michigan. She formerly was associate dean for research affairs at Indiana University School of Medicine and president and CEO of Riley Hospital for Children.


Cepheid said this week that its shareholders elected three new members to serve on its board of directors and three new committee members. The new members of the board of directors include Robert Easton, Hollings Renton, and Glenn Steele. The shareholders also appointed Christina Kepner to its audit committee, Dean Morton to the compensation committee, and Thomas Brown to its nominating and governance committee.


Illumina CFO Christian Henry said this week during a quarterly earnings call that the company has appointed Kevin Williams to be its new senior director of investor relations, a position he will take over incrementally over the coming quarter from Peter Fromen. Fromen will move into a new position at Illumina as senior director of applications marketing.


The Baylor Research Institute has appointed Yong-Jun Liu to be BRI's VP and CSO and director of the Baylor Institute for Immunology Research. Liu formerly was a professor and chair of the immunology department at the University of Texas M.D. Anderson Cancer Center, where he also is director of the Center for Cancer Immunology Research. Before M.D. Anderson, Liu was senior staff scientist at DNAX Research Institute of Molecular and Cellular Biology, and he worked at Schering-Plough and at the University of Birmingham.


GenMark Diagnostics has appointed Sue Pierce to be VP of product development. Pierce's diagnostics history includes 11 years spent at Ventana Medical Systems and 14 years at Abbott Laboratories. At Ventana, Pierce served as a VP of project management and development and a VP of integration and technical support. At Abbott, she worked in diagnostics, clinical chemistry, immunochemistry, and systems integration.


Verinata Health, formerly called Artemis Health, said that week that it has appointed Caren Mason to be CEO of the company and a member of its board of directors. Mason previously was president and CEO of diagnostics firm Quidel, and she has served as CEO at MiraMedica, a radiology software developer.


Arrowhead Research said that it has appointed City of Hope researcher John Rossi to the scientific advisory board of subsidiary Calando Pharmaceuticals. Rossi is one of Calando's co-founders. He also co-founded RNAi firm Dicerna Pharmaceuticals, and is a member of the SABs of Benitec and Kylin Therapeutics.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.